Growth impairment in children with pre-dialysis chronic kidney disease in Japan
Yuko Hamasaki(Toho University), Masataka Honda(Rikkyo University), Motoshi Hattori(Japanese Society for Dialysis Therapy), Tetsuji Kaneko(Teikyo University of Science), Shuichi Ito(Yokohama City University), Kenji Ishikura(Kitasato University), Yasuo Ohashi(Chuo University), Osamu Uemura(Aichi Medical University), Ryojiro Tanaka(Kobe Children's Hospital), Naohiro Wada(Shizuoka Children's Hospital), Koichi Nakanishi(University of the Ryukyus)
Cited by 17
Related Papers
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267